A combination of common medications and treatments can keep some, if not most, corona virus/CoV2-19 patients out of the hospital. That is information collated from the world’s medical literature that has been successful in all 37 of my confirmed CoV2-19 patients and who are 50% better in 1 day. If you are tested and positive for the corona virus, the monoclonal antibody infusion (ideally Evusheld) is a great place to start. When Merck’s molnupiravir, or likely better yet, Pfizer’s paxlovid are available, those are also recommended as first steps. An MD colleague analyst wrote this: “Some researchers are hesitant about using molnupiravir or paxlovid. The former is very likely to create large numbers of mutant strains and may be genotoxic. The latter has a whole range of CYP3A4/drug metabolism interactions involving dozens of common medications. The clinical trials results on these two drugs are no better than hydroxychloroquine (HCQ) and HCQ is unquestionably safer. One medication omitted is 8 mg TID bromhexine available over the counter, but not in the USA. There are a few trials showing benefit dosed at 8 mg TID: BUT can be obtained at https://buy-pharm.com/bromhexine-bromhexine-tablets-8-mg-50-pcs.html .”
I have used 7-9 of these below medications/supplements for 6 days or so quite effectively in combination since June, 2020. These readily available treatment options are routinely accessible to medical providers and can vastly reduce the symptoms and seriousness of the corona virus infection to just a bad cold and rarely anything more. Using several of these treatments, other health care providers and I have successfully avoided hospitalization for, while aiding recovery from, CoV2-19. This information should be widely available and recommended to providers and their patients in order to engage in a discussion about, and/or use of, these treatments:
– Methylprednisolone 8 mg TID 3 days BID 3 days QD 3days or Decadron/also known as dexamethasone (these steroids are similar to the natural stress hormone hydrocortisone produced by the adrenal glands)
– Asmanex/Alvesco asthma inhalers or steroid similars plus another asthma inhibitor Singulair/montelukast (to reduce lung inflammation) 10 mg QD
– Stomach acid and cold/viral reducers like Pepcid/famotidine, Halodine/povidone-iodine Nasal Antiseptic liquid packets
– Rosuvastatin 20 mg or other generic potent statin – For cholesterol lowering (statin)
– Tricor/fenofibrate – A triglyceride-blood fat treatment 145 mg
– Colchicine – An anti-inflammatory gout medicine (to calm general inflammation) 0.6 mg QD
– Fluvoxamine: an SSRI antidepressnat helpful with obsessive-compulsive disorder
– Ivermectin – Parasite treatment (inhibits host proteins): perhaps essential, perhaps not
– Lactoferrin – A milk derived immune enhancer that acts via inhibiting viral attachment to the cell when heparan (not heparin) is used for attachment and also immune protein involvement
– Metoprolol – A beta blocker “calms” the heart that may be under attack: used with resting heart rate above 80
– Low dose 81 mg aspirin – Also inhibits clotting
– Persantin/dipyridamole – Inhibits clotting 75 mg
– Hydroxychloroquine + azithromycin + zinc – Used as an antibiotic and corona virus “ionophore”. An option to Ivermectin
– Metformin – A diabetes medicine (effective in women-not routinely used)
A recently published and critiqued study of patients in Tlaxcala, Mexico confirmed this thinking. The aim of that study was to assess the effectiveness of a multidrug-therapy consisting of using ivermectin, azithromycin, montelukast and aspirin = acetylsalicylic acid (called “TNR4” therapy) to prevent hospitalization and death among ambulatory COVID-19 cases. The study was published in the International Journal of Infectious Disease. Nearly 85% of the patients in this study who received the TNR4 recovered within 14 days compared to 59% in the comparison group. The study concluded that the “…. likelihood of recovery within 14 days was 3.4 times greater among the TNR4 group than in the comparison group. Patients treated with TNR4 had a 75% and 81% lower risk of being hospitalized or death, respectively, than the comparison group.” In that article, the TNR4 therapy was shown to improve recovery and death as well as minimize hospitalization of COVID-19 cases.
This treatment does not keep the unvaccinated from getting the virus. Everyone who is not vaccinated, no matter their age, should continue following the common-sense preventive guidelines – double or KN-95 masking, social distancing, disinfecting contact surfaces, and thorough hand washing. Where possible, adding a high efficiency particulate filtering air purifier with UV light such as the Sun-Pure SP 60 can reduce infections by 50%. People under the age of 35 are clearly an exceptionally low risk category, but because of high omicron infectivity, relevant care is still necessary.
Since the arrival of the omicron variant, the infection rate is much higher and the public needs this guidance sooner. These are responsible precautions that everyone could do to avoid infection and spreading it to others since being vaccinated has not proven as effective with the omicron variant. These suggestions should be a part of our daily lives. Many “cases” are people simply colonized but even if infected, it would feel like a flu and can still be treated with the above. There is more to say.